Skip to main content
Allan Levey, MD, Neurology, Atlanta, GA, Emory University Hospital

AllanIraLeveyMDPhD, FANA

Neurology Atlanta, GA

Dementia & Geriatrics

Professor and Chairman of the Department of Neurology at Emory University, and he is Director of the Emory Alzheimer’s Disease Research Center. Dr. Levey has secondary faculty appointments in the Departments of Pharmacology and Psychiatry and Behavioral Sciences.

Dr. Levey is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Levey's full profile

Already have an account?

Summary

  • Dr. Allan Levey is a neurologist and neuroscientist in Atlanta, GA and is a faculty member at Emory University. He received his medical degree and PhD from University of Chicago Pritzker School of Medicine and has been in practice 33 years. He specializes in cognitive neurology.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Neurology, 1986 - 1989
  • Michael Reese Hospital and Medical Center
    Michael Reese Hospital and Medical CenterInternship, Internal Medicine, 1984 - 1985
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1984

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 1991 - 2025
  • NC State Medical License
    NC State Medical License 2020 - 2022
  • MD State Medical License
    MD State Medical License 1989 - 1992
  • IL State Medical License
    IL State Medical License 1985 - 1987
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults with Executive Mild Cognitive Impairment  
    Ihab Hajjar, Allan Levey, JAMA Network Open

Authored Content

  • Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults with Executive Mild Cognitive ImpairmentAugust 2020
  • Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults with Executive Mild Cognitive ImpairmentAugust 2020

Press Mentions

  • GA Health System to Deploy AI-Based Alzheimer’s Detection Tool
    GA Health System to Deploy AI-Based Alzheimer’s Detection ToolFebruary 23rd, 2023
  • Emory Healthcare Engages Linus Health on Initiative to Expand Early Detection of Alzheimer’s Disease and Other Dementias
    Emory Healthcare Engages Linus Health on Initiative to Expand Early Detection of Alzheimer’s Disease and Other DementiasFebruary 17th, 2023
  • Clinical Trials That Will Shape Medicine in 2023
    Clinical Trials That Will Shape Medicine in 2023February 2nd, 2023
  • Join now to see all

Grant Support

  • Emory Alzheimer'S Disease CenterNational Institute On Aging2010–2012
  • Lr11, A Novel Receptor In Mild Cognitive ImpairmentNational Institute On Aging2008–2012
  • Emory Neuroscience Ninds Core FacilitiesNational Institute Of Neurological Disorders And Stroke2008–2012
  • Administrative CoreNational Institute On Aging2005–2012
  • Training In Translational Research In NeurologyNational Institute Of Neurological Disorders And Stroke2004–2011
  • The Emory Alzheimer'S Disease CenterNational Institute On Aging2005–2009
  • Crossed Genetic Risk Of Alzheimer And Parkinson DiseaseNational Institute On Aging2005–2009
  • Muscarinic Receptors In Alzheimer'S DiseaseNational Institute Of Neurological Disorders And Stroke2005–2009
  • Medical Scientists Training ProgramNational Institute Of General Medical Sciences2002–2006
  • Muscarinic Receptor Proteins In Alzheimers DiseaseNational Institute Of Neurological Disorders And Stroke1994–2003
  • Genetic And Pathological Study Of Sporadic PDNational Institute Of Environmental Health Sciences2002
  • Monamine Transporters In ParkinsonismNational Institute Of Neurological Disorders And Stroke1998–2001
  • Medical Scientist Training ProgramNational Institute Of General Medical Sciences1997–2001
  • Emory Alzheimers Disease CenterNational Institute On Aging1999–2000
  • Core--ClinicalNational Institute On Aging1996–2000
  • Basal Ganglia--Molecular Pharmacology And AnatomyNational Institute Of Neurological Disorders And Stroke1996–1998
  • Minority Biomedical Research SupportNational Institute Of General Medical Sciences1994–1995
  • Muscarinic Receptor Proteins In Alzheimer'S DiseaseNational Institute Of Neurological Disorders And Stroke1991–1993
  • Localization Of Muscarinic Receptor Proteins M1-M5National Institute Of Neurological Disorders And Stroke1991
  • Localization Of Muscarinic Receptor Proteins M1-M5National Institute Of Neurological Disorders And Stroke1989–1991

Hospital Affiliations